European Archives - Page 1108 of 1159 - European Medical Journal

EMJ

CDK 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Richard Finn (UCLA, Los Angeles, CA) discusses the development of the cyclin…

EMJ

Ki67 as a marker for making management decisions in breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr John Bartlett (Ontario Institute for Cancer Research, Toronto, Canada) discusses…

EMJ

New drugs in neoadjuvant breast cancer therapy

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Sibylle Loibl (German Breast Group, Neu-Isenburg, Germany) discusses recent…

EMJ

Are randomised trials obsolete or more important than ever?

At the 14th St. Gallen International Breast Cancer Conference (SG-BCC) 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) Dr…

EMJ

Saunas Take the Heat Off Heart Disease

MEN who regularly use a sauna have a significantly lower risk of cardiovascular (CV) and all-cause mortality than those who attend less frequently.

EMJ

Fondaparinux the Best Option to Tackle NSTEMI?

DEATH and in-hospital bleeding in patients with non-ST-segment elevation myocardial infarction (NSTEMI) appears less likely through the use of…

EMJ

One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-Line Treatment Before Test Results Available

Geneva, Switzerland, 17 April 2015 — Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving…

EMJ

Smokers Underestimate Risks of a Few Cigarettes

Geneva, Switzerland, 17 April 2015 — Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day…

EMJ

NITID – Innovation in Skin Imaging Presented in Vienna

Madrid, April 16, 2015. DermaLumics presents NITID*, an innovative, non-invasive diagnosis tool for skin surface using Optical Coherence Tomography (OCT)…

EMJ

Evidence Grows That Melanoma Drugs Benefit Some Lung Cancer Patients

Geneva, Switzerland, 17 April 2015 — A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to…